Home / Centerstage / 2017 / march / Week 1 /
German company Sartorius AG agrees to acquire Essen BioScience Inc. for $320 million, as part of its strategy to expand its presence in the drug-discovery tools market. This purchase marks Sartorius' tenth acquisition in the past five years and highlights its commitment to strengthening its position in the life-sciences research-technology sector. With this move, Sartorius aims to enhance its offerings and better serve the biopharmaceutical-production tools market.
Monday, 6 March, 2017